약물 개발 서비스
약물 개발 서비스
The top 3 reasons why global pharmaceutical companies, biotechnology startups, and venture capital and private equity firms alike choose Certara:
1. Clients and partners choose us for our quantitative-driven approach. 당사는 전체 신약 개발 수명 주기에 걸쳐 모델링 및 시뮬레이션을 사용하여 프로그램의 위험을 낮추고 중요한 의사결정에 대한 확신을 강화하여 더 현명하고 신속하게 목표를 달성하도록 돕습니다.
2. We have the most experienced (and largest) team of experts with clinical pharmacologists, pharmacometricians, and regulatory scientists and writers, that is dedicated to achieve your success. Building relationships between our experts and your team is our focus. This is the reason our top 30 customers by revenue in 2022 have been with us for more than ten years on average.
3. Our proven track record speaks for itself. Certara는 종양학, 희귀 질환, 전염병, 신경퇴행성 질환 등 성공적인 협력을 통한 사례 연구 라이브러리를 보유하고 있습니다. Since 2014, customers who use our biosimulation software and technology-driven services have received 90% of all new drug approvals by the U.S. Food and Drug Administration (“FDA”).
How can Certara help your program?
Nonclinical Development Science
Drug Development Strategy
Clinical Pharmacology and Translational Medicine
Results matter
Since 2014, our customers have received over 90% of new drug and biologic approvals by the FDA. These FDA approvals span across several designations and therapeutic areas, including oncology, infectious disease, hematology, pulmonology, cardiology, dermatology, diabetes, neurology, gastroenterology, psychiatry, bone, migraine, sleep disorders and more. View the case studies below to see for yourself.
협력사를 위한 확실한 가치를 창출하는 것이 Certara의 최우선 과제입니다
Certara는 동급 최고의 능력을 활용하여 모델링 및 시뮬레이션, 규제 과학, 시장 접근성 영역에서 귀하의 팀과 협력해 중요한 결정을 위한 정보를 제공하고 규제 준수와 상업적 성공을 위한 준비를 완료해 드립니다.
Agility, communication, quality, and trust are paramount to the success of our partnerships. Together with you, we are one, integrated and cohesive team that anticipates risks, creates a robust strategy, and delivers with seamless implementation.
전략 미팅 예약하기
당사 초기 개발 전문가와의 미팅 일정을 예약하려면 아래 양식을 작성하세요.
